ATE541850T1 - Pyrroloä2,3-cüpyridinderivate als p38-kinase- hemmende mittel - Google Patents
Pyrroloä2,3-cüpyridinderivate als p38-kinase- hemmende mittelInfo
- Publication number
- ATE541850T1 ATE541850T1 AT09763363T AT09763363T ATE541850T1 AT E541850 T1 ATE541850 T1 AT E541850T1 AT 09763363 T AT09763363 T AT 09763363T AT 09763363 T AT09763363 T AT 09763363T AT E541850 T1 ATE541850 T1 AT E541850T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrroloä2
- cüpyridine
- derivatives
- kinase inhibitors
- kinase
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13192808P | 2008-06-13 | 2008-06-13 | |
| PCT/US2009/046551 WO2009152072A1 (en) | 2008-06-13 | 2009-06-08 | Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE541850T1 true ATE541850T1 (de) | 2012-02-15 |
Family
ID=40864629
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09763363T ATE541850T1 (de) | 2008-06-13 | 2009-06-08 | Pyrroloä2,3-cüpyridinderivate als p38-kinase- hemmende mittel |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20110105430A1 (de) |
| EP (1) | EP2300485B1 (de) |
| JP (1) | JP5511805B2 (de) |
| CN (1) | CN102203101B (de) |
| AR (1) | AR072008A1 (de) |
| AT (1) | ATE541850T1 (de) |
| AU (1) | AU2009257712B2 (de) |
| CA (1) | CA2727315A1 (de) |
| ES (1) | ES2380120T3 (de) |
| MX (1) | MX2010013629A (de) |
| TW (1) | TW200951133A (de) |
| WO (1) | WO2009152072A1 (de) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR072008A1 (es) * | 2008-06-13 | 2010-07-28 | Merck & Co Inc | Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38 |
| PH12012500778A1 (en) | 2009-10-30 | 2012-11-26 | Janssen Pharmaceutica Nv | IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| AR080754A1 (es) | 2010-03-09 | 2012-05-09 | Janssen Pharmaceutica Nv | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 |
| CN102372707B (zh) * | 2010-08-16 | 2015-08-19 | 上海药明康德新药开发有限公司 | 6-甲基-4-溴-1,6-二氢吡咯[2,3-c]吡啶-7-酮的合成方法 |
| US20120079818A1 (en) * | 2010-09-30 | 2012-04-05 | Svihla Gary R | Filtration arrangement for an exhaust aftertreatment system for a locomotive two-stroke diesel engine |
| TWI541241B (zh) * | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類 |
| WO2012087833A1 (en) | 2010-12-22 | 2012-06-28 | Abbott Laboratories | Hepatitis c inhibitors and uses thereof |
| WO2012122586A1 (en) * | 2011-03-15 | 2012-09-20 | Phosphagenics Limited | New composition |
| JP6115962B2 (ja) | 2011-06-27 | 2017-04-19 | ヤンセン ファーマシューティカ エヌ.ベー. | 1−アリール−4−メチル−[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体 |
| WO2014001314A1 (en) | 2012-06-26 | 2014-01-03 | Janssen Pharmaceutica Nv | Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders |
| EA025186B1 (ru) | 2012-06-29 | 2016-11-30 | Пфайзер Инк. | НОВЫЕ 4-(ЗАМЕЩЕННЫЙ АМИНО)-7Н-ПИРРОЛО[2,3-d]ПИРИМИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ LRRK2 |
| AU2013289284B2 (en) | 2012-07-09 | 2017-03-30 | Janssen Pharmaceutica Nv | Inhibitors of phosphodiesterase 10 enzyme |
| US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| CN105073747B (zh) | 2013-03-15 | 2017-06-06 | 普莱希科公司 | 杂环化合物及其应用 |
| GB201321738D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic Agents |
| EP3083618B1 (de) | 2013-12-17 | 2018-02-21 | Pfizer Inc | Neuartige 3,4-disubstituierte-1h-pyrrolo[2,3-b]pyridine und 4,5-disubstituierte 7h-pyrrolo[2,3-c]pyridazine als lrrk2-hemmer |
| GB201506660D0 (en) * | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
| RU2722149C1 (ru) | 2015-09-14 | 2020-05-27 | Пфайзер Инк. | Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2 |
| US10973761B2 (en) | 2015-12-09 | 2021-04-13 | Phosphagenics Limited | Pharmaceutical formulation |
| JP7198754B2 (ja) | 2016-12-21 | 2023-01-04 | アベーチョ バイオテクノロジー リミテッド | 方法 |
| WO2019055877A1 (en) | 2017-09-15 | 2019-03-21 | Forma Therapeutics, Inc. | TETRAHYDROIMIDAZO QUINOLINE COMPOSITIONS AS INHIBITORS OF CBP / P300 |
| ES2927715T3 (es) | 2017-10-05 | 2022-11-10 | Fulcrum Therapeutics Inc | Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD |
| US10717735B2 (en) | 2017-10-13 | 2020-07-21 | Plexxikon Inc. | Solid forms of a compound for modulating kinases |
| IL279734B2 (en) | 2018-06-29 | 2024-11-01 | Forma Therapeutics Inc | Inhibiting creb binding protein (cbp) |
| TW202102494A (zh) | 2019-03-15 | 2021-01-16 | 美商弗瑪治療公司 | 抑制環amp-反應元件-結合蛋白(creb) |
| US11801243B2 (en) | 2020-09-23 | 2023-10-31 | Forma Therapeutics, Inc. | Bromodomain inhibitors for androgen receptor-driven cancers |
| US11795168B2 (en) | 2020-09-23 | 2023-10-24 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (CREB) binding protein (CBP) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0201261A3 (en) * | 1999-05-21 | 2003-12-29 | Scios Inc Sunnyvale | Indole-type derivatives as inhibitors of p38 kinase and pharmaceutical compositions containing them |
| GB0222743D0 (en) * | 2002-10-01 | 2002-11-06 | Celltech R&D Ltd | Chemical compounds |
| TWI339206B (en) * | 2003-09-04 | 2011-03-21 | Vertex Pharma | Compositions useful as inhibitors of protein kinases |
| MY153898A (en) * | 2005-06-22 | 2015-04-15 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| BRPI0620196A2 (pt) * | 2005-12-23 | 2013-01-15 | Astrazeneca Ab | composto, processo para a preparaÇço do mesmo, composiÇço farmacÊutica, uso de um composto, e, mÉtodos para a produÇço de um efeito antibacteriano em um animal de sangue quente, para a inibiÇço de dna girase e/ou topoisomerase iv bacteriana em um animal de sangue quente e para o tratamento de uma infecÇço bacteriana em um animal de sangue quente |
| MX2009005264A (es) * | 2006-12-06 | 2009-05-28 | Boehringer Ingelheim Int | Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos. |
| AR072008A1 (es) * | 2008-06-13 | 2010-07-28 | Merck & Co Inc | Compuestos heterobiciclicos como agentes de inhibicion de quinasa p38 |
-
2009
- 2009-06-04 AR ARP090102007A patent/AR072008A1/es unknown
- 2009-06-06 TW TW098118954A patent/TW200951133A/zh unknown
- 2009-06-08 CN CN200980131581.XA patent/CN102203101B/zh not_active Expired - Fee Related
- 2009-06-08 US US12/997,524 patent/US20110105430A1/en not_active Abandoned
- 2009-06-08 AU AU2009257712A patent/AU2009257712B2/en not_active Ceased
- 2009-06-08 JP JP2011513599A patent/JP5511805B2/ja not_active Expired - Fee Related
- 2009-06-08 WO PCT/US2009/046551 patent/WO2009152072A1/en not_active Ceased
- 2009-06-08 CA CA2727315A patent/CA2727315A1/en not_active Abandoned
- 2009-06-08 AT AT09763363T patent/ATE541850T1/de active
- 2009-06-08 MX MX2010013629A patent/MX2010013629A/es active IP Right Grant
- 2009-06-08 ES ES09763363T patent/ES2380120T3/es active Active
- 2009-06-08 EP EP09763363A patent/EP2300485B1/de active Active
- 2009-06-10 US US12/481,614 patent/US8017605B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009257712B2 (en) | 2014-06-12 |
| EP2300485A1 (de) | 2011-03-30 |
| MX2010013629A (es) | 2011-01-14 |
| US20110105430A1 (en) | 2011-05-05 |
| EP2300485B1 (de) | 2012-01-18 |
| CN102203101B (zh) | 2014-12-03 |
| AR072008A1 (es) | 2010-07-28 |
| US20090325953A1 (en) | 2009-12-31 |
| WO2009152072A1 (en) | 2009-12-17 |
| AU2009257712A1 (en) | 2009-12-17 |
| ES2380120T3 (es) | 2012-05-08 |
| US8017605B2 (en) | 2011-09-13 |
| CA2727315A1 (en) | 2009-12-17 |
| JP5511805B2 (ja) | 2014-06-04 |
| CN102203101A (zh) | 2011-09-28 |
| TW200951133A (en) | 2009-12-16 |
| JP2011524354A (ja) | 2011-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2019009I2 (el) | Αναστολεις πρωτεϊνικων κινασων | |
| LTC2300013I2 (lt) | Fosforo dariniai kaip kinazių inhibitoriai | |
| ATE506358T1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
| ATE545417T1 (de) | Pyrazoloä3,4-büpyridin-derivate als phosphodiesterasehemmer | |
| ATE493411T1 (de) | Pyrroloä2, 3-büpyridin-4-yl- benzolsulfonamidverbindungen als ikk2-hemmer | |
| ATE555107T1 (de) | 2-aza-bicyclo-ä2,2,1-üheptan-derivate | |
| NO2021006I1 (no) | Quofenix, delafloksacin | |
| ATE518860T1 (de) | Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren | |
| BRPI0906973A2 (pt) | Compostos e composições como inibidores de cinase. | |
| BRPI0918846A2 (pt) | inibidores de cinase heterocíclica | |
| DK2300459T3 (da) | Nye fenylpyrazinoner som kinasehæmmere | |
| ATE549340T1 (de) | Spiroindolinon-derivate als mdm2-p53 inhibitoren | |
| BRPI0811434A2 (pt) | imidazopiridazinas como inibidores de pi3k lipídeo cinase. | |
| DK1926722T3 (da) | Substituerede benzimidazoler som kinaseinhibitorer | |
| SI2201012T1 (sl) | Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B | |
| LT3354650T (lt) | Junginiai, naudingi kaip atr kinazės inhibitoriai | |
| DK2308877T3 (da) | Imidazopyridin-2-on-derivater | |
| DK2294066T3 (da) | Benzoimidazoler som prolylhydroxylaseinhibitorer | |
| ZA201101118B (en) | Picolinamide derivatives as kinase inhibitors | |
| ATE546444T1 (de) | Amidophenoxyindazole als c-met-hemmer | |
| DK2285786T3 (da) | Quinoxalindion-derivater | |
| DK2344471T3 (da) | 7-piperidinalkyl-3,4-dihydroquinolon-derivat | |
| ATE467623T1 (de) | Diazepan-acetamidderivate als selektive 11-hsd1- hemmer | |
| DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
| CR10879A (es) | Cyclized derivatives as eg-5 inhibitors |